Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × Neoadjuvant Therapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Medulloblastoma 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 38 fludarabine 24 Methotrexate 21 Vincristine 20 fludarabine phosphate 18 Cytarabine 18 blinatumomab 17 Dexamethasone 16 venetoclax 11 Whole-Body Irradiation 11 Mycophenolic Acid 11 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 Mercaptopurine 10 Tacrolimus 9 Hydrocortisone 9 Filgrastim 9 Stem Cell Transplantation 8 Rituximab 8 Mesna 8 Etoposide 8 Doxorubicin 8 Calcium Dobesilate 8 Busulfan 8 pegaspargase 7 merphos 7 calaspargase pegol 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 ponatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡